Forthcoming Articles

International Journal of Business Continuity and Risk Management

International Journal of Business Continuity and Risk Management (IJBCRM)

Forthcoming articles have been peer-reviewed and accepted for publication but are pending final changes, are not yet published and may not appear here in their final order of publication until they are assigned to issues. Therefore, the content conforms to our standards but the presentation (e.g. typesetting and proof-reading) is not necessarily up to the Inderscience standard. Additionally, titles, authors, abstracts and keywords may change before publication. Articles will not be published until the final proofs are validated by their authors.

Forthcoming articles must be purchased for the purposes of research, teaching and private study only. These articles can be cited using the expression "in press". For example: Smith, J. (in press). Article Title. Journal Title.

Articles marked with this shopping trolley icon are available for purchase - click on the icon to send an email request to purchase.

Online First articles are also listed here. Online First articles are fully citeable, complete with a DOI. They can be cited, read, and downloaded. Online First articles are published as Open Access (OA) articles to make the latest research available as early as possible.

Open AccessArticles marked with this Open Access icon are Online First articles. They are freely available and openly accessible to all without any restriction except the ones stated in their respective CC licenses.

Register for our alerting service, which notifies you by email when new issues are published online.

International Journal of Business Continuity and Risk Management (One paper in press)

Regular Issues

  • Critical Success Factors to Promote Enterprise Risk Management and Business Performance in Pharmaceutical Companies: a Systematic Review   Order a copy of this article
    by Xing Su, Siew Chin Ong 
    Abstract: This study identifies the critical success factors(CSFs) influencing enterprise risk management (ERM), and business performance in the pharmaceutical industry. Expectedly, all identified CSFs were designed to have a positive impact on the implementation of ERM. Consequently, we developed a comprehensive research framework to guide future research. Given the scale of the systematic review, we identified via a thorough screening process a carefully selected compendium of research articles. After extracting and analysing the relevant information from these papers, we rightly identified and highlighted that the survey was the most recognized and predominant research method, emphasized five commonly used CSFs and several business performance indicators. Besides, this study recognized effective tools for evaluating ERM systems. By integrating these insights, this research established a fundamental framework that addressed gaps in the fragmented literature, which previously lacked an integrated analysis of interrelationships, and proposed several specific opportunities for future research.
    Keywords: Critical success factor; enterprise risk management; Tobin's ; Enterprise Risk Management Index; pharmaceutical company.
    DOI: 10.1504/IJBCRM.2026.10077878
     

 

Return to top